Hi everyone -

We are planning for some changes in administration of alteplase given a shortage of 100mg vials. The manufacturer recommendations note to place into an empty bag but that is not a typical bedside process for us. Has anyone investigated other options? Or have plans for safeguards for the bedside transfer to bag?

Thanks

Hi everyone -

We are planning for some changes in administration of alteplase given a shortage of 100mg vials. The manufacturer recommendations note to place into an empty bag but that is not a typical bedside process for us. Has anyone investigated other options? Or have plans for safeguards for the bedside transfer to bag?

Thanks

Hi everyone -

We were made aware of an upcoming shortage of alteplase and are reviewing approaches for safeguarding administration with the use of 50mg vials. The manufacturer recommendations are to place product in empty bags however that's not a typical bedside process at our institution. Has anyone been reviewing alternative or options? And/or what types of safeguards are being employed for the bedside prep by manufacturer instructions?

Thanks

When you compound your chemotherapy preparations, do you account for overfill vs the final labeled volume?
1. Remove "estimated" volume of overfill.
2. Add "estimated" volume of overfill to the final volume on the label.
3. Pump bags to exact base fluid volume stated on the label.
4. Do not account for overfill in the final volume stated on the label.

-How are your patients monitored, if at all, when they receive medications for pain or anxiolysis prior to imaging?
-Do you have criteria when a RN must accompany for monitoring?
-Is the primary RN monitoring the patient or is it a RN from MRI/CT?
-Are you using capnography?
Thanks in advance,
Stacie Ethington MSN, RN-BC
Nebraska Medicine

For those of you with outpatient pharmacies within your system, how do you notify patients that a medication they were previously taking has been automatically substituted to another medication? We are looking to prevent patients from taking both the old medication and the new substituted medication.

What is your process for patients who come to the pharmacy to pick up their med?

What is your process for patients who have their medications delivered to them?

Wondering if any facilities have a current policy on handling oral chemotherapy agents when patients are admitted from home for non-oncology indications. Does anyone hold these medications until an oncologist determines the appropriateness of continuing the medication? We have had a couple instances where the home medication was continued, but the reason for admission was an adverse effect of their oral chemotherapy agent. Anyone else have a process/workflow in place they would be willing to share?
Thanks -
Maria Cumpston, PharmD, CPPS
Medication Safety Officer

Hi Everyone,

There are a lot of different practices I'm seeing out there for management of insulin drip adsorption.

1. Let it dwell?

2. 20 ML priming flush?

3. No safeguard as it's being used with a carefully monitored titration protocol?

4. Other ideas?

We are currently exploring the idea of a flush, but are curious to hear from others.

Thanks,
Zach

Good Afternoon,

We are in the process of review/revision of our syringe pump drug library, specific for OR. Would anyone be willing to share their library?

Thank you.

With the increase in medications given EUA status for COVID, what is your process for receiving, monitoring, and communicating EUA updates and action items to involved staff? including regularly checking Fact Sheets and keeping the EHR systems updated. Thank you!